RBC Capital Increases Target Price on Boston Scientific Corporation (BSX) to $125

Boston Scientific Corporation continues to make headlines in the stock market, capturing investor attention with consistent innovation and a promising growth trajectory. RBC Capital Markets, one of the most respected financial institutions in the investment world, recently raised its target price on Boston Scientific Corporation (BSX) shares to $125, up from $120. This price increase is a strong signal that the company is performing well and is expected to continue its upward trend.